Radius Health, Inc. (RDUS) Social Stream
RADIUS HEALTH INC (RDUS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RDUS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 6 | $30 | $18 | $23.142 | $10.08 | 129.58% |
| 2021-12-03 | 7 | $30 | $16 | $22.125 | $10.08 | 119.49% |
| 2021-12-09 | 7 | $30 | $9 | $15.875 | $10.08 | 57.49% |
| 2021-12-10 | 7 | $30 | $7 | $14.5 | $10.08 | 43.85% |
| 2022-02-01 | 6 | $20 | $7 | $11 | $10.08 | 9.13% |
| 2022-03-14 | 6 | $12 | $7 | $9.666 | $10.08 | -4.11% |
| 2022-04-25 | 6 | $13 | $7 | $9.833 | $10.08 | -2.45% |
| 2022-05-05 | 6 | $13 | $7 | $9.666 | $10.08 | -4.11% |
| 2022-05-11 | 6 | $13 | $7 | $9.333 | $10.08 | -7.41% |
| 2022-05-19 | 6 | $14 | $7 | $9.5 | $10.08 | -5.75% |
| 2022-05-24 | 7 | $14 | $6.25 | $9.035 | $10.08 | -10.37% |
| 2022-06-08 | 8 | $14 | $7 | $9 | $10.08 | -10.71% |
| 2022-08-09 | 6 | $10 | $8 | $9.333 | $10.08 | -7.41% |
The Trend in the Analyst Price Target
RDUS's average price target has moved down $15.24 over the prior 13 months.
Over the past 49 weeks, RDUS's average upside potential has been 47.24%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-28 | 8 | 31 | 15 | 22.140 | 13.66 | 62.08% |
| 2021-09-09 | 8 | 31 | 15 | 22.140 | 13.00 | 70.31% |
| 2022-02-25 | 6 | 12 | 7 | 9.666 | 8.26 | 17.02% |
| 2022-04-25 | 6 | 13 | 7 | 9.833 | 7.21 | 36.38% |
| 2022-06-08 | 8 | 14 | 7 | 9.000 | 7.28 | 23.63% |
RDUS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 6 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
RDUS's average broker recommendation rating improved by 0.5 over the prior 30 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RDUS as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, RADIUS HEALTH INC's average analyst price target is greater than 251.93% of them.
- RDUS has a greater upside potential (average analyst target price relative to current price) than 551.16% of all US stocks.
- RADIUS HEALTH INC's variance in analysts' estimates is lower than -1150.81% of stocks in the mid market cap category.
- RADIUS HEALTH INC's number of analysts covering the stock is greater than 741.58% of stocks in the mid market cap category.
Stocks similar to RADIUS HEALTH INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RCUS, RCKT, and QURE.
View All Top Stocks by Price Target
Make investment decisions regarding RDUS using the data that counts. Try POWR Ratings for free.